Amino acid PET and clinical management of glioma patients

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 4, 2010, Pages 683-684

  Herholz, Karl ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; METHIONINE C 11;

CANCER GRADING; CANCER PATIENT; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; GLIOMA; HUMAN; ISOTOPE LABELING; ISOTOPE TRACING; NOTE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY ANALYSIS;

BRAIN NEOPLASMS; CARBON RADIOISOTOPES; DECISION MAKING; GLIOMA; HUMANS; METHIONINE; PATIENT CARE PLANNING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 77952099457     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1366-8     Document Type: Note

References (11)

1. S Cha 2006 Update on brain tumor imaging: from anatomy to physiology AJNR Am J Neuroradiol 27 475 487 1:STN:280:DC%2BD287mtFyrtA%3D%3D 16551981 (Pubitemid 44897763)
2. EB Claus PM Black 2006 Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001 Cancer 106 1358 1363 10.1002/cncr.21733 16470608 (Pubitemid 43363915)
3. A Jacobs 1995 Amino acid uptake in ischemically compromised brain tissue Stroke 26 1859 1866 1:STN:280:DyaK28%2FisVyhtA%3D%3D 7570739
4. TB Johannesen F Langmark K Lote 2003 Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993 J Neurosurg 99 854 862 10.3171/jns.2003.99.5.0854 14609165 (Pubitemid 37314921)
5. B Pirotte S Goldman O Dewitte N Massager D Wikler F Lefranc, et al. 2006 Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures J Neurosurg 104 238 253 10.3171/jns.2006.104.2.238 16509498 (Pubitemid 43304323)
6. G Pöpperl C Götz W Rachinger FJ Gildehaus JC Tonn K Tatsch 2004 Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma Eur J Nucl Med Mol Imaging 31 1464 1470 10.1007/s00259-004-1590-1 15248032 (Pubitemid 39592765)
7. MJB Taphoorn M Klein 2004 Cognitive deficits in adult patients with brain tumours Lancet Neurol 3 159 168 10.1016/S1474-4422(04)00680-5 14980531 (Pubitemid 38229950)
8. N Tsuyuguchi I Sunada K Ohata T Takami A Nishio M Hara, et al. 2003 Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine Ann Nucl Med 17 47 51 10.1007/BF02988258 12691130 (Pubitemid 36417573)
9. MJ van den Bent ME Hegi R Stupp 2006 Recent developments in the use of chemotherapy in brain tumours Eur J Cancer 42 582 588 10.1016/j.ejca.2005.06.031 16427778 (Pubitemid 43343679)
10. M Weckesser KJ Langen CH Rickert S Kloska R Straeter K Hamacher, et al. 2005 O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours Eur J Nucl Med Mol Imaging 32 422 429 10.1007/s00259-004-1705-8 1:STN:280:DC%2BD2M7osleiuw%3D%3D 15650870 (Pubitemid 40591174)
11. T Yamane S Sakamoto M Senda 2010 Clinical impact of 11C-methionine PET on expected management of patients with brain neoplasm Eur J Nucl Med Mol Imaging 10.1007/s00259-009-1302-y 19915838